• Rasagiline Tablets

    Free

    Product Composition & Strength

    We supply this product as a Precision-Blended Uncoated or Film-Coated Tablet, packed exclusively in highly secure, moisture-resistant Alu-Alu blister strips to ensure the absolute chemical stability of the highly sensitive mesylate salt.

    Active IngredientStrengthPrimary Clinical Function
    Rasagiline Mesylate INN/Ph.Eur.0.5 mg (Base Equivalent)Adjunct Standard: Initiating dose when used in combination with Levodopa.
    Rasagiline Mesylate INN/Ph.Eur.1 mg (Base Equivalent)Global Clinical Standard: Maximum daily dose for monotherapy or advanced adjunct therapy.
    ExcipientsMannitol / Maize Starch / Pregelatinized Starch / Colloidal Silicon Dioxide / Stearic AcidDiluent / Binder / Superdisintegrant / Glidant (Engineered for immediate gastric dissolution and rapid crossing of the blood-brain barrier)

    *Pack Sizes: 10×10 Alu-Alu Blisters or 3×10 Unit-Dose Blisters (Optimized specifically for strict high-compliance 30-day chronic neurology dispensing regimens).